Transforming remote cardiac care
Digital cardiac biomarkers that shift the economics of cardiovascular care through smartphones.
News (Global)
Jan 24 , 2024
CardioSignal raises $10M in Series A as the first technology to detect major heart diseases without specialized hardware
Apr 8, 2024
CardioSignal Presents a New Clinical Modality for Heart Failure Detection Using Smartphones
Mar 14, 2024
Whitepaper: Implementing population health programs for earlier detection of atrial fibrillation
Software as a Medical Device
✔ A patented technology that measures heart motion to assess cardiac function
✔ Unrivalled accessibility – works with a smartphone application (no additional hardware required), reaching millions of at-risk patients in remote areas
✔ Available in 15 countries (Europe, India) as a class IIa medical device for detecting signs of atrial fibrillation
✔ For population health models, point-of-care, remote patient monitoring, platform and device integrations, clinical trials
Soon available in the USA
Where to
meet us next?
ATA Nexus, May 5-7 / Phoenix, AZ
HLTH Europe, June 17-20 / Amsterdam, Netherlands
Patented motion sensor technology
Method
Gyrocardiography, a non-invasive technique for measuring heart motion with a gyroscope and accelerometer
Scientific basis
Technology based on 10+ years of academic research and 20+ peer-reviewed publications
Clinical studies
Validated in clinical studies, with continuous focus on academic collaboration